Skip to main content

Table 5 Patients in the total population candidates to drug treatment (lipid lowering or antihypertensive) according to recommendations in the European Guidelines on Cardiovascular Disease Prevention using the SCORE and D'Agostino equations.

From: Therapeutic implications of selecting the SCORE (European) versus the D'AGOSTINO (American) risk charts for cardiovascular risk assessment in hypertensive patients

 

With SCORE

With D'Agostino

p

Antihypertensive treatment

   

Overall

65 (32%)

68 (33.5%)

0.453

Males

48 (40.7%)

51 (43.2%)

0.453

Females

17 (20%)

17 (20%)

1

Lipid lowering treatment

   

Overall

63 (15.8%)

109 (27.3%)

0.000

Males

51 (22.7%)

89 (39.6%)

0.000

Females

12 (6.9%)

20 (11.5%)

0.008

  1. P value of differences in treatment based on European Guidelines on Cardiovascular Disease Prevention between both scales.